Consensus Sanofi Bulgaria S.E.

Equities

Real-time Estimate Tradegate Other stock markets 02:54:55 2024-07-09 am EDT			5-day change	1st Jan Change
92.6 ^EUR	+3.59%		0.00%	+5.96%

Jul. 08	Kymera Reports Expansion of KT-474 Trials; Shares Rise After-Hours	MT
Jul. 08	Kymera Therapeutics, Inc. Announces Expansion of KT-474 HS and AD Phase 2 Studies Following Interim Review of Safety and Efficacy	CI

892acd.pXboQo5dr76Oh9vxMt_yktEXS_YweJnfQ1EjzLUYUcs.8jWnNcE5_I6j8Ja5eIyH3YF_eM5FH7SZAGlU4c1eaJLkHZA33Szri8XVkg~98d016e56cd3b1de89a87b333eea4467

SANOFI : Jefferies maintains a Buy rating	Jul. 08	ZD
SANOFI : Stifel slightly raises its target on the stock	Jul. 08	CF
SANOFI : Berenberg reiterates its Buy rating	Jul. 03	ZD
SANOFI : JP Morgan remains Neutral	Jul. 03	ZD
SANOFI : Jefferies reaffirms its Buy rating	Jul. 02	ZD
SANOFI : Receives a Buy rating from Berenberg	Jul. 02	ZD
SANOFI : UBS remains its Buy rating	Jun. 25	ZD
SANOFI : JP Morgan sticks Neutral	Jun. 24	ZD
SANOFI : UBS reiterates its Buy rating	Jun. 04	ZD
SANOFI : Gets a Neutral rating from JP Morgan	Jun. 03	ZD
SANOFI : Sell rating from Deutsche Bank	May. 13	ZD
SANOFI : Berenberg maintains a Buy rating	May. 13	ZD
Novavax Stock Price More Than Doubles After COVID-19 Vaccine Licensing Deal With Sanofi	May. 10	MT
SANOFI : UBS gives a Buy rating	May. 10	ZD
HEDGE FUND SHAH CAPITAL SAYS NOVAVAX-SANOFI DEAL IS "A STEP IN T…	May. 10	RE
HEDGE FUND SHAH CAPITAL - NOVAVAX-SANOFI DEAL CONCURS WITH SHAH…	May. 10	RE
SANOFI : JP Morgan reaffirms its Neutral rating	May. 10	ZD
Bank of America, BNP Set to Win Lead Roles on Sanofi's Consumer-Healthcare Spin Off	May. 06	MT
SANOFI : Buy rating from UBS	May. 06	ZD
SANOFI : Jefferies reiterates its recommendation on the stock	Apr. 29	CF
SANOFI : Deutsche Bank gives a Sell rating	Apr. 29	ZD
SANOFI : JP Morgan remains Neutral	Apr. 29	ZD
SANOFI : DZ Bank reaffirms its Neutral rating	Apr. 25	ZD
SANOFI : Jefferies reiterates its Buy rating	Apr. 25	ZD
SANOFI : Sanofi’s healthy Q1 performance hailed by markets	Apr. 25

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

92.1 EUR

Average target price

108.2 EUR

Spread / Average Target

+17.46%

High Price Target

125 EUR

Spread / Highest target

+35.72%

Low Price Target

80 EUR

Spread / Lowest Target

-13.14%

Trading Rating

Investor Rating

ESG Refinitiv